AbsEn.i
Analysis
2020
Racine
Analysis
2020
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Analysis (2020)

Index « AbsEn.i » - entrée « three »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
threatening < three < threshold  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 18.
Ident.Authors (with country if any)Title
000051 (2020) Eun Hye Park [Corée du Sud] ; Eun Young Lee [Corée du Sud] ; Kichul Shin [Corée du Sud] ; Hyoun-Ah Kim [Corée du Sud]Tocilizumab-induced anaphylaxis in patients with adult-onset Still's disease and systemic juvenile idiopathic arthritis: a case-based review.
000055 (2020) Pan Luo [République populaire de Chine] ; Yi Liu [République populaire de Chine] ; Lin Qiu [République populaire de Chine] ; Xiulan Liu [République populaire de Chine] ; Dong Liu [République populaire de Chine] ; Juan Li [République populaire de Chine]Tocilizumab treatment in COVID-19: A single center experience.
000067 (2020) Thomas Maldiney [France] ; Clémence Deschasse [France] ; Philip Bielefeld [France]Tocilizumab for the Management of Corticosteroid-Resistant Mild to Severe Graves' Ophthalmopathy, a Report of Three Cases.
000230 (2020) Josef S. Smolen [Autriche] ; Jung-Yoon Choe [Corée du Sud] ; Michael E. Weinblatt [États-Unis] ; Paul Emery [Royaume-Uni] ; Edward Keystone [Canada] ; Mark C. Genovese [États-Unis] ; Gihyun Myung [Corée du Sud] ; Evelyn Hong [Corée du Sud] ; Inyoung Baek [Corée du Sud] ; Jeehoon Ghil [Corée du Sud]Pooled analysis of TNF inhibitor biosimilar studies comparing radiographic progression by disease activity states in rheumatoid arthritis
000305 (2020) Susanne H. C. Baumeister [États-Unis] ; Benedetta Rambaldi [États-Unis, Italie] ; Roman M. Shapiro [États-Unis] ; Rizwan Romee [États-Unis]Key Aspects of the Immunobiology of Haploidentical Hematopoietic Cell Transplantation
000309 (2020) Florian Moretto ; François-Xavier Catherine ; Clémentine Esteve ; Mathieu Blot [France] ; Lionel Piroth [France]Isolated Anti-HBc: Significance and Management
000318 (2020) Peter Uciechowski [Allemagne] ; Wolfram C M. Dempke [Allemagne]Interleukin-6: A Masterplayer in the Cytokine Network.
000326 (2020) Phillip Sommer ; Elvedin Lukovic [États-Unis] ; Eliot Fagley [États-Unis] ; Dustin R. Long [États-Unis] ; Julia B. Sobol [États-Unis] ; Katherine Heller ; Vivek K. Moitra [États-Unis] ; Ronald Pauldine [États-Unis] ; Michael F. O Onnor ; Sajid Shahul ; Mark E. Nunnally ; Avery TungInitial Clinical Impressions of the Critical Care of COVID-19 Patients in Seattle, New York City, and Chicago
000379 (2020) Jeremiah Au ; Frederick T. Gibson [États-Unis] ; Iris K. AronsonFollicular occlusion triad: an isotopic response or adverse effect of rituximab?
000434 (2020) Rahime Koç [Turquie] ; Hafize Emine Sönmez [Turquie] ; Mustafa Çakan [Turquie] ; Erife Gül Karada [Turquie] ; Ay E Tanatar [Turquie] ; Figen Çakmak [Turquie] ; Nuray Aktay Ayaz [Turquie]Drug reactions in children with rheumatic diseases receiving parenteral therapies: 9 years' experience of a tertiary pediatric rheumatology center.
000438 (2020) Boris Fehse [Allemagne] ; Anita Badbaran [Allemagne] ; Carolina Berger [Allemagne] ; Tanja Sonntag [Allemagne] ; Kristoffer Riecken [Allemagne] ; Maria Geffken [Allemagne] ; Nicolaus Kröger [Allemagne] ; Francis A. Ayuk [Allemagne]Digital PCR Assays for Precise Quantification of CD19-CAR-T Cells after Treatment with Axicabtagene Ciloleucel
000441 (2020) Ruei-Min Lu [Taïwan] ; Yu-Chyi Hwang [Taïwan] ; I-Ju Liu [Taïwan] ; Chi-Chiu Lee [Taïwan] ; Han-Zen Tsai [Taïwan] ; Hsin-Jung Li [Taïwan] ; Han-Chung Wu [Taïwan]Development of therapeutic antibodies for the treatment of diseases
000469 (2020) Jehun Song [Corée du Sud] ; Seongmin Kang [Corée du Sud] ; Seung Won Choi [Corée du Sud] ; Kwang Won Seo [Corée du Sud] ; Sunggun Lee [Corée du Sud] ; Min Wook So [Corée du Sud] ; Doo-Ho Lim [Corée du Sud]Coronavirus Disease 19 (COVID-19) complicated with pneumonia in a patient with rheumatoid arthritis receiving conventional disease-modifying antirheumatic drugs
000514 (2020) Fatih Ha Lak [Turquie] ; Mehmet Y Ld Z [Turquie] ; Amra Adrovic [Turquie] ; Kenan Barut [Turquie] ; Özgür Kasapçopur [Turquie]Childhood Rheumatic Diseases and COVID-19 Pandemic: An Intriguing Linkage and a New Horizon
000538 (2020) Debasish Banerjee [Royaume-Uni] ; Joyce Popoola [Royaume-Uni] ; Sapna Shah [Royaume-Uni] ; Irina Chis Ster [Royaume-Uni] ; Virginia Quan [Royaume-Uni] ; Mysore Phanish [Royaume-Uni]COVID-19 infection in kidney transplant recipients
000565 (2020) Ali Aminian [États-Unis] ; Mohammad Kermansaravi [Iran] ; Shahriar Azizi [Iran] ; Peyman Alibeigi [Iran] ; Sina Safamanesh [Iran] ; Ali Mousavimaleki [Iran] ; Mohammad Taghi Rezaei [Iran] ; Maziar Faridi [Iran] ; Somayeh Mokhber [Iran] ; Abdolreza Pazouki [Iran] ; Saeed Safari [Iran]Bariatric Surgical Practice During the Initial Phase of COVID-19 Outbreak
000568 (2020) Charlotte Laurent [France] ; Zora Marjanovic [France] ; Laure Ricard [France] ; Joerg Henes [Allemagne] ; Remy Dulery [France] ; Manuela Badoglio [France] ; Dominique Farge [France] ; John A. Snowden [Royaume-Uni] ; Daniela Moraes [Brésil] ; Juliana Dias [Brésil] ; Mohamad Mohty [France] ; Michael Soussan [France] ; Olivier Fain [France] ; Renate Arnold [Allemagne] ; Tobias Alexander [Allemagne] ; Maria-Carolina Oliveira [Brésil] ; Arsène Mekinian [France]Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning regimens in refractory Takayasu arteritis: a retrospective multicenter case-series from the Autoimmune Diseases Working Party (ADWP) of the European Society for Blood and Marrow Transplantation (EBMT).
000598 (2020) Angelo Fassio [Italie] ; Giovanni Adami [Italie] ; Alessandro Giollo [Italie] ; Ombretta Viapiana [Italie] ; Nazzarena Malavolta [Italie] ; Gianantonio Saviola [Italie] ; Roberto Bortolotti [Italie] ; Luca Idolazzi [Italie] ; Francesco Bertoldo [Italie] ; Maurizio Rossini [Italie] ; Davide Gatti [Italie]Acute Effects of Glucocorticoid Treatment, TNFα or IL-6R Blockade on Bone Turnover Markers and Wnt Inhibitors in Early Rheumatoid Arthritis: A Pilot Study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/2020/Analysis

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i -k "three" 

HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/AbsEn.i  \
                -Sk "three" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    2020
   |étape=   Analysis
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    three
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021